ACAZEN Trademark

Trademark Overview


On Thursday, November 21, 2019, a trademark application was filed for ACAZEN with the United States Patent and Trademark Office. The USPTO has given the ACAZEN trademark a serial number of 79275472. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG. The ACAZEN trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological pre...
acazen

General Information


Serial Number79275472
Word MarkACAZEN
Filing DateThursday, November 21, 2019
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253453
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesNutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlpinia Institute for Life Sciences AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameAlpinia Laudanum Institute of Phytopharmaceutical Sciences AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameAlpinia Laudanum Institute of Phytopharmaceutical Sciences AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, June 7, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 15, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 30, 2021GENERIC MADRID TRANSACTION SENT TO IB
Thursday, April 29, 2021GENERIC MADRID TRANSACTION CREATED
Monday, April 26, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Sunday, November 8, 2020NOTIFICATION PROCESSED BY IB
Wednesday, October 21, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 21, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, October 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, September 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 10, 2020REFUSAL PROCESSED BY IB
Tuesday, March 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 24, 2020REFUSAL PROCESSED BY MPU
Wednesday, March 4, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 3, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 25, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB